Alkermes Plc (ALKS)
44.30
+1.85
(+4.36%)
USD |
NASDAQ |
Jun 09, 16:00
44.30
0.00 (0.00%)
After-Hours: 20:00
Alkermes EPS Diluted (Quarterly) : -0.40 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.501 |
| Prothena Corp. Plc | 0.6047 |
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| Inovio Pharmaceuticals, Inc. | -0.2848 |
| Agios Pharmaceuticals, Inc. | -1.686 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -66.48M |
| Revenue (Quarterly) | 392.91M |
| Total Expenses (Quarterly) | 459.39M |
| Enterprise Value | 8.136B |
| Gross Profit Margin (Quarterly) | 80.92% |
| Profit Margin (Quarterly) | -16.92% |
| Earnings Yield | 2.03% |
| Operating Earnings Yield | 2.58% |
| Normalized Earnings Yield | 2.031 |